an online repository for sharing of antimicrobial susceptibility data 2 associated with whole genome sequences. 
The decreased costs of next generation sequencing (NGS) combined with the progress made in big 42 data analysis such as machine leaning (ML) represent innovative opportunities to tackle the AMR 43 crisis 3 . Many bacterial phenotypic traits, including AMR, can be directly linked to the presence of 44 genomic determinants such as genes, Single Nucleotide Polymorphism's (SNPs) or transcription 45 promoters which can be identified using functional genomics approaches on large databases of 46 genomes. Recent studies have used computational approaches such as ML to predict antimicrobial 47 susceptibility from genomic data or to discover previously unidentified antibiotic resistance 48 determinants [4] [5] [6] . Today, the major limitation for such approaches is not the lack of advanced 49 computational methods or hardware resources but the lack of large enough well curated, annotated 50 data sets where phenotypic AMR data and genomes are linked. 51
Academic research initiatives and public health organisations could benefit from the implementation 52 of online repositories capable of storing large amounts of genome sequence and antimicrobial 53 susceptibility testing (AST) data. . The concept was developed and introduced as a model 91 for rapid sharing of data and analysis outputs in public and pre-publication confidential status within 92 the COMPARE consortium. Data hubs are restricted (by login and password) to the members of the 93 project authorized to access the data. Pre-publication confidential data sharing between partners has 94 been considered only in projects where immediate release of data/metadata was not possible, i.e. 95 sensitive content has been awaiting publication, but partners needed access to confidential data for 96
analysis. Ultimately, all data archived in data hubs are released into the public domain (the standard 97 ENA database) after a period defined by data owners. Data and metadata reported by data providers 98 are submitted to the hubs through systematic processes supported by a number of tools. 99
Subsequently, structured and accessioned data/metadata are available for sharing between data 100 consumers who have received consent from data providers. Data appropriate for a given 101 computational analysis are selected and fed autonomously through cloud-based analysis workflows 102 of which the outputs -"derived" data products -are fed back into the system. 103 104
The antibiogram 105
In order to represent AST data, we have defined a new data type, the "antibiogram", for use within 106 the AMR data hub and, more broadly, within ENA. This new data type leverages the extensible 107 "analysis object" system, with the addition of a new class specifically for the storage of phenotypic 108 AMR data, designated "AMR_ANTIBIOGRAM". Antibiograms are treated as data objects within the 109 system and are supported in data submission and access services. 
Visualisation tools 142
To visualize the contents of the AMR data hub, a Notebook was configured (Figure 1 ) that has several 143 options for comparison of a defined set of parameters from the database, such as the distribution of 144 the minimal inhibitory concentration (MIC) of different antimicrobials as a function of the country of 145 origin, or the comparison of MIC distributions between different antimicrobials. As such, this 146 functionality can be used for surveillance purposes, providing a rapid overview of MIC distribution for 147 a specific collection of isolates and how this compares to isolates from the same host or from 148 different geographical regions. 149
The Notebook is integrated into the Pathogen portal and can be accessed from 150 https://www.ebi.ac.uk/ena/pathogens/home under the "Explore" tab. Access to pre-publication data 151 in the AMR data hub requires authentication via login and password with authorization to the 152 corresponding project. 153 which is based on more than 20,000 isolates (https://mic.eucast.org/Eucast2/). 174
Phylogenetic analysis 175
As an example of the possibilities offered by the AMR data hub, the entire collection of E. coli 176 genomes was downloaded and a phylogenetic analysis of the population, in relation to ciprofloxacin 177
MICs, was performed (methods in supplementary materials). As shown in Figure 3 , this population is 178 highly diverse and features a large range of ciprofloxacin MICs. Several isolates tend to cluster by 179 country, such as those from Denmark or Vietnam. Additionally, a strong association between 180 resistance and country can be observed. Most isolates from Vietnam show an MIC higher than 2 181 mg/ml. The study during which these isolates were collected focused on the presence of ESBL genes 182 in E. coli 12 and it is possible that ciprofloxacin resistance was co-selected for, as was previously 183 suggested 13 . Additionally, 24 out of 30 isolates retrieved from the CDC antimicrobial resistance 184 isolate bank (https://www.cdc.gov/drugresistance/resistance-bank/currently-available.html) 185 exhibited an MIC of 8 mg/ml. This unusually high proportion of resistant isolates can be explained by 186 the purpose of the CDC database, which is to provide a panel of well characterized resistant bacteria 187 for testing of diagnostic devices and new antibiotic agents. Conversely, isolates from Denmark were 188 collected as part of a routine surveillance effort from the veterinary institute and appear to all be 189 susceptible to ciprofloxacin. 
Discussion

198
We have built the AMR data hub with aim to provide a system for public health, food and veterinary 199 institutes, clinical laboratories and researchers to share their genomic and related AST data. It can be 200
used for standardized open-access data sharing, for example for published data, thus creating an 201 ever-growing source of AST metadata available to researchers worldwide. The large volume of data 202 made available will make it easier to use advanced statistical methods such as machine-learning to 203 predict AMR phenotypes from genomic data and discover new AMR determinants. 204
It has been recently underlined that application of the Nagoya Protocol, which regulates material and 205 data sharing, to genetic information might threaten the timely sharing of data in times of public 206 health emergencies 14 . In allowing the organisation and sharing of linked genomics and AST data, the 207 AMR data hub promotes openness and accessibility for these important data types while at the same 208 time meeting the privacy concerns for pre-publication data. Considering the exponential rise in the 209 number of bacterial genomes available, and the threat to modern medicine represented by the rise 210 of AMR, the establishment of the AMR data hub represents a timely effort to improve collaboration 211 in this field. 212
The design of a standard data submission format benefited from the expertise of the COMPARE 213 consortium, a group of international experts in bacterial genomics and AMR surveillance and 214 research. It is designed to be as exhaustive, and at the same time as flexible as possible to ensure 215 easy sharing of AST data. The database is hosted at the EMBL-EBI, ensuring its connection to the 216 world's largest online repository of bacterial genomes. 217
As members of the INSDC, EMBL-EBI and NCBI are part of a joined effort for standardization and 218
sharing of genomic data. The NCBI can also host antibiograms in a similar format to that presented 219 here, and efforts are currently ongoing to allow automated synchronization of content from both 220
sides. This will greatly increase the flexibility and the reach of the AMR data hub. While NCBI data 221 must be made public immediately upon deposition, EBI allows for pre-publication data to be kept 222 private for a provider-defined period. Participating institutions can thus choose whether they want 223 their data to be open-access immediately or whether they prefer sharing it with selected members of 224 a consortium before public release. 225
The view is that the AMR data hub will soon become an essential resource for functional genomic 226 studies of AMR. By encouraging data providers from different fields and geographical origin to share 227 their data, this collection can greatly improve our ability to answer questions related to the current 228 AMR crisis. 229 230 231
